Fanconi Anemia Gene Variants in Patients with Gonadal Dysfunction

被引:11
作者
Daum, Hagit [1 ]
Zlotogora, Joel [2 ,3 ]
机构
[1] Hebrew Univ Jerusalem, Fac Med, Dept Genet, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Dept Genet, Hadassah Med Org, Jerusalem, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
关键词
Fanconi anemia; Gonadal dysfunction; Azoospermia; Primary ovarian insufficiency; Mosaic; Hypomorphic variants; MUTATIONS; CANCER; BRCA2; XRCC2;
D O I
10.1007/s43032-021-00582-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Fanconi anemia (FA) is a multisystem disease, characterized by the triad of physical abnormalities, bone marrow failure, and increased risk for malignancy. In the past few years, data has accumulated regarding fertility issues in FA patients, mostly due to gonadal dysfunction, which is prevalent in FA patients reaching puberty. It seems that attenuated FA phenotype lacking the classical manifestations often is presented with POI or azoospermia. Searching the literature, we summarized data regarding FA patients presenting as suffering from sub/infertility due to gonadal dysfunction, with or without other FA symptoms. We present a summary of the patients having biallelic pathogenic variants in FA genes FANCA, FANCM, BRCA2, and XRCC2 that presented with gonadal dysfunction with or without other phenotypic features of FA. Some were in mosaic, while some are considered hypomorphic, enabling residual protein function. There are also a few descriptions of POI associated with monoallelic pathogenic variants in FANCA, BRCA2, and FANCL. We conclude that the diagnosis of FA in gonadal dysfunction patients is of utmost importance due to its actionability. Follow-up strategies in FA patients are designed to discover early stages of leukemias and solid tumors and thus save lives. The feasibility of next-generation sequencing (NGS) can now ease this diagnostic procedure. An open question is the justification of performing NGS for all isolated azoospermia/POI patients.
引用
收藏
页码:1408 / 1413
页数:6
相关论文
共 50 条
  • [21] Comprehensive Analysis of Pathogenic Deletion Variants in Fanconi Anemia Genes
    Flynn, Elizabeth K.
    Kamat, Aparna
    Lach, Francis P.
    Donovan, Frank X.
    Kimble, Danielle C.
    Narisu, Narisu
    Sanborn, Erica
    Boulad, Farid
    Davies, Stella M.
    Gillio, Alfred P., III
    Harris, Richard E.
    MacMillan, Margaret L.
    Wagner, John E.
    Smogorzewska, Agata
    Auerbach, Arleen D.
    Ostrander, Elaine A.
    Chandrasekharappa, Settara C.
    HUMAN MUTATION, 2014, 35 (11) : 1342 - 1353
  • [22] Characterization of Fanconi Anemia Patients with Head and Neck Squamous Cell Carcinoma: Israel Fanconi Registry
    Tsur, Nir
    Frig, Omri
    Steinberg-Shemer, Orna
    Tamary, Hannah
    Kurman, Noga
    Mizrachi, Aviram
    Popovtzer, Aron
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (08): : 491 - 496
  • [23] Four novel mutations of the Fanconi anemia group A gene (FAA) in Japanese patients
    Nakamura, A
    Matsuura, S
    Tauchi, H
    Hanada, R
    Ohashi, H
    Hasegawa, T
    Honda, K
    Masuno, M
    Imaizumi, K
    Sugita, K
    Ide, T
    Komatsu, K
    JOURNAL OF HUMAN GENETICS, 1999, 44 (01) : 48 - 51
  • [24] Diagnosis of Fanconi anemia in patients without congenital malformations: An international Fanconi anemia registry study
    Giampietro, PF
    Verlander, PC
    Davis, JG
    Auerbach, AD
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 68 (01): : 58 - 61
  • [25] Evaluation of Rare Variants in the New Fanconi Anemia Gene ERCC4 (FANCQ) as Familial Breast/Ovarian Cancer Susceptibility Alleles
    Osorio, Ana
    Bogliolo, Massimo
    Fernandez, Victoria
    Barroso, Alicia
    de la Hoya, Miguel
    Caldes, Trinidad
    Lasa, Adriana
    Ramon y Cajal, Teresa
    Santamarina, Marta
    Vega, Ana
    Quiles, Francisco
    Lazaro, Conxi
    Diez, Orland
    Fernandez, Daniel
    Gonzalez-Sarmiento, Rogelio
    Duran, Mercedes
    Fernandez Piqueras, Jose
    Marin, Maria
    Pujol, Roser
    Surralles, Jordi
    Benitez, Javier
    HUMAN MUTATION, 2013, 34 (12) : 1615 - 1618
  • [26] Clinical characteristics and genetic subtypes of Fanconi anemia in Saudi patients
    Ghazwani, Yahya
    AlBalwi, Mohammed
    Al-Abdulkareem, Ibrahim
    Al-Dress, Mohammed
    Alharbi, Talal
    Alsudairy, Reem
    Alomari, Ali
    Aljamaan, Khalid
    Essa, Mohammed
    Al-Zahrani, Mohsen
    Alsultan, Abdulrahman
    CANCER GENETICS, 2016, 209 (04) : 171 - 176
  • [27] Analysis of 65 Turkish patients with congenital aplastic anemia (Fanconi anemia and non-Fanconi anemia): Hacettepe experience
    Altay, C
    Alikasifoglu, M
    Kara, A
    Tuncbilek, E
    Ozbek, N
    SchroederKurth, TM
    CLINICAL GENETICS, 1997, 51 (05) : 296 - 302
  • [28] The molecular biology of Fanconi anemia
    Tamary, H
    Bar-Yam, R
    Zemach, M
    Dgany, O
    Shalmon, L
    Yaniv, I
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (10): : 819 - 823
  • [29] Fanconi Anemia and Laron Syndrome
    Castilla-Cortazar, Inma
    Rodriguez de Ita, Julieta
    Amador Aguirre, Gabriel
    Castorena-Torres, Fabiola
    Ortiz-Urbina, Jesus
    Garcia-Magarino, Mariano
    Garcia de la Garza, Rocio
    Diaz Olachea, Carlos
    Elizondo Leal, Martha Irma
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 353 (05) : 425 - 432
  • [30] Targeted gene therapy and cell reprogramming in Fanconi anemia
    Rio, Paula
    Banos, Rocio
    Lombardo, Angelo
    Quintana-Bustamante, Oscar
    Alvarez, Lara
    Garate, Zita
    Genovese, Pietro
    Almarza, Elena
    Valeri, Antonio
    Diez, Begona
    Navarro, Susana
    Torres, Yaima
    Trujillo, Juan P.
    Murillas, Rodolfo
    Segovia, Jose C.
    Samper, Enrique
    Surralles, Jordi
    Gregory, Philip D.
    Holmes, Michael C.
    Naldini, Luigi
    Bueren, Juan A.
    EMBO MOLECULAR MEDICINE, 2014, 6 (06) : 835 - 848